Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Delayed Tolerance Through Mixed Chimerism

NCT05900401 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT05900401
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05900401 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Delayed Tolerance Through Mixed Chimerism
Lead sponsor
Massachusetts General Hospital
Phase
Phase 1/2
Overall status
Recruiting
Start date
October 1, 2023
Completion date
December 31, 2032
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chimera, kidney failure, kidney transplant; complications